Adocia SAS operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Adocia SAS with three other
companies in this sector in France:
Innate Pharma S.A.
sales of 17.91 million Euro [US$19.66 million]
of which 100%
was Licensing Revenue),
(56.39 million Euro [US$61.89 million]
of which 101%
was Therapeutics), and
(22.51 million Euro [US$24.71 million]
Sales increased substantially in 2015:
Adocia SAS reported sales of 36.94 million Euro (US$40.54 million)
December of 2015.
increase of 5,146.6%
versus 2014, when the company's sales were 704,000.00 Euro.